5-Bromo-2-chloroisonicotinic acid

We are 5-Bromo-2-chloroisonicotinic acid CAS:886365-31-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Bromo-2-chloroisonicotinic acid
CAS.NO:886365-31-7
Synonyms:5-Bromo-2-chloroisonicotinic acid
5-Bromo-2-chloropyridine-4-carboxylic acid
 
Physical and Chemical Properties:
Density 1.9±0.1 g/cm3
Boiling Point 419.3±45.0 °C at 760 mmHg
Molecular Formula C6H3BrClNO2
Molecular Weight 236.451
Flash Point 207.4±28.7 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.630
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

5-Bromo-2-chloroisonicotinic acid


Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.4-(methylamino)-3-nitrobenzoyl chloride CAS:82357-48-0 With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near1003709-96-3 The World Health Organisation (WHO) describes coronaviruses as a large family of viruses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China.334-61-2 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
1,1,2,2,3-pentachlorocyclopropane View Details
2-(Dimethylamino)Isopropyl Chloride Hydrochloride View Details
4-Methylpiperidine View Details
4-Chlorophenylboronic acid manufacturer Light Stabilizer 3529 manufacturer 4-Methylphenylboronic Acid manufacturer Calcium 3-hydroxybutyrate manufacturer 3,3,3-Trifluoro-n-propylamine hydrochloride Cas:2968-33-4 manufacturer